Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Bate

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Plos Biology|September 29, 2017
The Experimental Design AssistantNathalie Percie du Sert, Ian Bamsey, Simon T Bate, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 7, 1999
Clinical delivery of intensity modulated conformal radiotherapy for relapsed or second-primary head and neck cancer using a multileaf collimator with dynamic controlW De Neve, W De Gersem, S Derycke, et al.
Journal of Neuroinflammation|February 28, 2007
Repeated administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque load in mice bearing amyloid precursor protein and presenilin-1 mutant transgenesPerdita L Pugh, Martin P Vidgeon-Hart, Tracey Ashmeade, et al.
Oncotarget|April 9, 2016
High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibitionLaurel T Bate-Eya, Ilona J M den Hartog, Ida van der Ploeg, et al.
European Journal of Cancer (Oxford, England : 1990)|December 11, 2013
Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumoursLaurel T Bate-Eya, Marli E Ebus, Jan Koster, et al.
Brain Research|March 11, 2009
Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS1 mice using MRISatheesh Maheswaran, Hervé Barjat, Daniel Rueckert, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 21, 2014
Characterization of the novel positive allosteric modulator of the metabotropic glutamate receptor 4 ADX88178 in rodent models of neuropsychiatric disordersMikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, et al.
Molecular Cancer Therapeutics|April 14, 2021
High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma CellsLindy Vernooij, Laurel T Bate-Eya, Lindy K Alles, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Plos Biology|September 29, 2017
The Experimental Design AssistantNathalie Percie du Sert, Ian Bamsey, Simon T Bate, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 7, 1999
Clinical delivery of intensity modulated conformal radiotherapy for relapsed or second-primary head and neck cancer using a multileaf collimator with dynamic controlW De Neve, W De Gersem, S Derycke, et al.
Journal of Neuroinflammation|February 28, 2007
Repeated administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque load in mice bearing amyloid precursor protein and presenilin-1 mutant transgenesPerdita L Pugh, Martin P Vidgeon-Hart, Tracey Ashmeade, et al.
Oncotarget|April 9, 2016
High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibitionLaurel T Bate-Eya, Ilona J M den Hartog, Ida van der Ploeg, et al.
European Journal of Cancer (Oxford, England : 1990)|December 11, 2013
Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumoursLaurel T Bate-Eya, Marli E Ebus, Jan Koster, et al.
Brain Research|March 11, 2009
Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS1 mice using MRISatheesh Maheswaran, Hervé Barjat, Daniel Rueckert, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 21, 2014
Characterization of the novel positive allosteric modulator of the metabotropic glutamate receptor 4 ADX88178 in rodent models of neuropsychiatric disordersMikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, et al.
Molecular Cancer Therapeutics|April 14, 2021
High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma CellsLindy Vernooij, Laurel T Bate-Eya, Lindy K Alles, et al.
Pageof 4